Does DABIGATRAN ETEXILATE Cause Haematemesis? 308 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 308 reports of Haematemesis have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.8% of all adverse event reports for DABIGATRAN ETEXILATE.
308
Reports of Haematemesis with DABIGATRAN ETEXILATE
0.8%
of all DABIGATRAN ETEXILATE reports
106
Deaths
229
Hospitalizations
How Dangerous Is Haematemesis From DABIGATRAN ETEXILATE?
Of the 308 reports, 106 (34.4%) resulted in death, 229 (74.4%) required hospitalization, and 73 (23.7%) were considered life-threatening.
Is Haematemesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 308 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Haematemesis?
ASPIRIN (1,538)
RIVAROXABAN (1,085)
CLOPIDOGREL BISULFATE (954)
IBUPROFEN (836)
APIXABAN (650)
ADALIMUMAB (563)
ACETAMINOPHEN (454)
WARFARIN (426)
SERTRALINE (412)
ENOXAPARIN (404)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Haematemesis Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB